AddLife (ALIF B.ST) Azione Prezzo
AddLife Prezzo
Il fatturato è cresciuto a un tasso composto del 20,7% annuo negli ultimi 13 anni, raggiungendo 10,44 miliardi SEK. L'utile per azione è cresciuto del 16,9% all'anno negli ultimi 13 anni. Il margine netto di AddLife si attesta al 5,4%, in calo rispetto al 9,0% di alcuni anni fa. AddLife offre attualmente un rendimento da dividendo di circa il 0,44%. Il payout ratio è pari a circa il 16% degli utili. Il dividendo è cresciuto del 9,1% all'anno negli ultimi 8 anni. Gli analisti fissano un target di prezzo mediano di 218,28 SEK, ovvero il 27,9% sopra il prezzo attuale. Su 8 analisti, 5 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
AddLife Prezzo delle azioni
AddLife Azione e analisi azionaria
Domande frequenti sull'azione AddLife
The business model of AddLife AB revolves around the distribution and marketing of high-quality products and services within the life science sector. AddLife AB primarily focuses on three business areas: Labtech, Medtech, and Diagnostics. Labtech involves offering innovative solutions, including equipment and consumables, to laboratories and research institutions. Medtech includes the distribution of medical technology products for healthcare and rehabilitation. Diagnostics encompasses the supply of diagnostic products and services for medical laboratories. AddLife AB aims to provide its customers with comprehensive solutions, strong expertise, and reliable deliveries to meet their needs in the life science industry.
AddLife AB is primarily active in the industries of life sciences and healthcare.
The main competitors of AddLife AB in the market are its industry peers, such as Getinge AB, Lifco AB, and Elekta AB.
AddLife AB is a Swedish company specializing in the distribution and sales of high-quality products for the healthcare sector. Founded in 2016, AddLife has quickly become a leading player in the Nordic region, providing services and solutions within the fields of laboratory equipment, diagnostics, and biotechnology. The company focuses on areas such as research, healthcare, and life science, offering a wide range of products from renowned global manufacturers. With its extensive expertise and strong market presence, AddLife continues to evolve and expand its operations, driving advancements in healthcare and contributing to the well-being of individuals and society as a whole.
AddLife AB, a leading company in the life science sector, has achieved several notable milestones. The company has successfully expanded its presence and market share, becoming a key player in the industry. AddLife AB has made strategic acquisitions, enhancing its product portfolio and geographical reach. Additionally, it has formed collaborations with renowned partners, reinforcing its position as an innovative and reliable partner in the life science field. The company's steadfast commitment to customer satisfaction and focus on delivering high-quality products and services have contributed to its continued success and growth. AddLife AB's dedication to excellence has led to significant achievements and recognition within the life science industry.
AddLife AB is primarily present in Sweden and Finland.
AddLife AB is a leading company that represents strong values and a robust corporate philosophy. They prioritize customer satisfaction and strive to deliver exceptional products and services. AddLife AB values integrity, professionalism, and continuous improvement in everything they do. With a focus on innovation and sustainability, the company aims to create long-term value for both stakeholders and society as a whole. By providing high-quality healthcare solutions and fostering partnerships, AddLife AB demonstrates their commitment to improving people's lives.
Gli analisti fissano attualmente un prezzo obiettivo medio di 208,59 SEK per l’azione AddLife (mediana: 218,28 SEK), pari a +22,3 % rispetto all’ultimo prezzo. Il consenso si basa su 8 giudizi di analisti.
8 analisti valutano attualmente l’azione AddLife: 5 raccomandano l’acquisto, 3 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per AddLife ricavi pari a 10,90 miliardi SEK e un utile per azione di 6,28 SEK.
Convertita al tasso di cambio attuale, l’azione AddLife quota 15,22 EUR (170,60 SEK).
L’azione AddLife (ALIF B.ST) è quotata su 6 borse, tra cui: London (0REZ.L), Frankfurt (1AD1.F), München (1AD1.MU), Stockholm (ALIF B.ST).
The Swedish company AddLife AB is a B2B company that offers products and solutions for the healthcare sector. The company focuses on four main business areas: Life Science, Labtech, Medtech, and Healthcare. AddLife offers its customers a wide range of products, services, and solutions in these areas. In the Life Science area, AddLife offers products and solutions for the research and development of pharmaceutical and biotechnology companies. This includes, for example, analysis instruments, laboratory equipment and chemicals, as well as consumables. The Labtech area specializes in laboratory equipment. This includes, for example, workstations, technical systems, and consumables. Software solutions for the execution and evaluation of experiments are also part of the offer. In the Medtech area, AddLife offers products and solutions for diagnostics and therapy. This includes, for example, instruments for cardiology or laboratory medicine, as well as consumables for medical examinations. Special products for infection control are also offered. In the Healthcare area, AddLife offers products and solutions for nursing and rehabilitation. This includes, for example, aids for mobility promotion, products for wound care or incontinence care. AddLife does not sell its products and solutions directly to end customers, but to companies and institutions in the healthcare sector such as hospitals, practices, or research institutes. AddLife follows a clear strategy to expand and develop its business. This includes, for example, acquisitions, cooperations, and networking. This way, AddLife can expand its product portfolio and use the expertise of its partners. The internationalization of the business also plays an important role. AddLife is already active in several countries worldwide and plans to further expand its business. The business model of AddLife is based on long-term customer relationships and a high quality of products and services. AddLife works closely with its customers and offers them customized solutions. Customers can benefit from the extensive experience and expertise of AddLife. In summary, AddLife is an innovative and future-oriented company that offers products and solutions for the healthcare sector. Through its clear strategy, high quality products and services, and collaboration with partners and customers, AddLife aims to further expand its business and strengthen its position in the market.
Il attesa fatturato di AddLife ammonta a 10,90 miliardi SEK. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di AddLife ammonta a 765,18 Mio. SEK. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di AddLife è attualmente 27,17. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione AddLife.
Il rapporto prezzo/fatturato (P/S) di AddLife è attualmente 1,91. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione AddLife.
Il Quality Score AlleAktien per AddLife è 4/10.
L'ISIN di AddLife è SE0014401378. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di AddLife è A2P4TH. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di AddLife è ALIF B.ST. Con questo simbolo di borsa vengono negoziate le azioni AddLife in borsa.
Azione AddLife
Altre metriche e analisi di AddLife in Deep Dive.
La nostra analisi azionaria dell'azione AddLife include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di AddLife. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: